Mental Disorders

643 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Mental Disorders
Treatment and conditionWhere it standsTrials
(2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg) + Placebo for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
(2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg) + Placebo for major depressive disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
[F-18]Flornaptitril for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
100 mg for sexual dysfunctions, psychologicalTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
40 Hz sound stimulation for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
40 Hz Synchronous Audio-Visual Stimulation for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
50 mg qhs for sexual dysfunctions, psychologicalTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
AADvac1 for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
AADvac1 for pick disease of the brainTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
AB-1001 Gene Therapy for huntington diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Abbott Laboratories Infinity™ implantable deep brain stimulation system for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Academic Competency Enhancement (ACE) classroom for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Accelerated protocol of home Transcranial direct current stimulation for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Accelerated theta-burst stimulation treatment for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Accelerated theta-burst stimulation treatment for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Acceptance and Commitment Therapy + Ketamine for alcoholismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Acceptance-Based Behavior Therapy (ABBT) for anxiety disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Acetylcysteinamide for dementiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Activa Tremor Control Sys (DBS Implant) for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Activa Tremor Control Sys (DBS Implant) for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Active - Conventional tDCS for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Active - HD tDCS for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
active rTMS treatment for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
active rTMS treatment for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Active tDCS for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
active tDCS + mindfulness meditation for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
active tDCS stimulating left DLPFC for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Active tDCS with Sternberg task for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Active tDCS with Sternberg task for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Active transcranial direct current stimulation for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Active Whole-Body Hyperthermia (Active WBH) for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Acupuncture for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
acupuncture (strong reaction acupoints) + SSRIs for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
acupuncture (weak reaction acupoints) + SSRIs for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
acupuncture + placebo for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
acupuncture + SSRIs for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
acupuncture and moxibustion for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
AD04 for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
AD5-NCOV for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Administer Leqemi 10 mg/kg, every two weeks. for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Aducanumab for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)4
Aducanumab for cognitive dysfunctionTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Aerobic exercise intervention for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Aia for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)3
Ambroxol for dementiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ambroxol hydrochloride for lewy body diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Amygdala neurofeedback for borderline personality disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
App AURORA (Digital Therapy) + conventional treatment for generalized anxiety disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Arbaclofen for autism spectrum disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Aripiprazole for bipolar disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Aripiprazole for major depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Aripiprazole for psychotic disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Aripiprazole for schizophreniaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Aripiprazole + IEM (Ingestible Event Marker) for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Aripiprazole + IEM (Ingestible Event Marker) for schizophreniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Art and physical activity program. for anxiety disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Aticaprant for major depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
ATTN201 Focused Ultrasound to the CMN for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
ATTN201 Focused Ultrasound to the CMN for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Atuzaginstat for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Audiovisual stimulation VR system for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Audiovisual stimulation VR system for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Auricular Acupuncture for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Azetukalner for major depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Baclofen for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Baclofen for anxiety disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
BBB opening for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Behavioral Activation for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Behavioural Activation (BA) Therapy for bipolar disorderTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Behavioural Activation (BA) Therapy for depressive disorder, treatment-resistantTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Behavioural Activation (BA) Therapy for major depressive disorderTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Benzocaine Gel applied to the cervix + Hydroxyzine Hydrochloride for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Bexicaserin for neurodevelopmental disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bilateral implantation of DBS system to Habeluna for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Blood Brain Barrier (BBB) Disruption for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Blue-depleted evening light condition for mental disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
BPL-003 for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Brenipatide for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Brenipatide for opioid-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brief Cognitive Behavioral Conjoint Therapy (bCBCT) + MIDOMAFETAMINE for stress disorders, post-traumaticPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brief cognitive task-based intervention for psychological traumaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Brief cognitive task-based intervention for stress disorders, post-traumaticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Brief Negotiation Interview for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brief Negotiation Interview + Naltrexone + Gabapentin for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Buntanetap for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Buntanetap tartrate for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Buntanetap tartrate for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bupropion + Escitalopram + Venlafaxine + SERTRALINE for bipolar disorderTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Bupropion + Escitalopram + Venlafaxine + SERTRALINE for major depressive disorderTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Bupropion + Escitalopram + Venlafaxine + SERTRALINE for schizophreniaTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Cabotegravir for substance-related disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cal-Mag Butyrate for cognition disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cannabidiol for marijuana abusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Cannabidiol for psychotic disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Cannabidiol + Dronabinol for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet + Naproxen 500 Mg + Opioids for opioid-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
CBCT + Therapy + MIDOMAFETAMINE for stress disorders, post-traumaticPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cca for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cervical Lymphatic Microsurgery for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cervical Lymphaticovenous and Lymph Node-to-Vein Anastomosis for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Chlorhexidine for erectile dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cholecalciferol for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cholecalciferol for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
chronobiological augmentation for bipolar disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
chronobiological augmentation for major depressive disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
CI-581a for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
CI/BNST stimulation for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CI/BNST stimulation + ITP Stimulation + No stimulation for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CI/BNST stimulation + No stimulation for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Clinical assessment + salivary collections of amylase and cortisol + Stress elicitation experiment + Structural and Functional MRI for borderline personality disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Clozapine for bipolar disorderTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Clozapine for major depressive disorderTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Clozapine for schizophreniaTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Cognitive Behavioral Therapy (CBT) for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cognitive Behavioral Therapy (CBT) + Whole-Body Hyperthermia for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cognitive Behavioral Therapy (CBT) + Whole-Body Hyperthermia (WBH) for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cognitive Behavioral Therapy + Psilocybin for major depressive disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cognitive Processing Therapy for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cognitive task + Left DLPFC tDCS for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cognitive task + Right DLPFC tDCS for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cognitive Training for psychotic disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cognitive Training + Personalized neuroprotective strategies : Vitamin B12, folinic acid, Omega 3, NAC for psychotic disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Combination of Neostigmine and Glycopyrrolate + I-Box by Dynatronics for encopresisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Combined LAI Treatment: Cabenuva and Sublocade for opioid-related disordersTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Combined metabolic activators for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Communication Bridge™ for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Communication Bridge™ for aphasia, primary progressivePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Contingency management for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Counseling + Biospecimen Collection + Interview + Survey Administration + Psilocybin for depressive disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Counseling + Quitting using Medication for substance-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Counseling + Switching to E-Cigarette for substance-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth) for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Crisugabalin for generalized anxiety disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Curcumin for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Curcumin and Fluoxetine for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cyclobenzaprine hydrochloride for stress disorders, traumatic, acutePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
D-Cycloserine (DCS) for combat disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
D-Cycloserine (DCS) for stress disorders, post-traumaticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Daoib for dementiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Daridorexant for alcoholismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dbs for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dbs for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DBS + No Stimulation (Sham) for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DBS of the NAc for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DBS system for obsessive-compulsive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DC-LVA treatment plus usual care for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Simulator for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation for anorexia nervosaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation for autistic disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation for gamblingTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Deep Brain Stimulation for obsessive-compulsive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)3
Deep Brain Stimulation for schizophreniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation (DBS) for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation Model 3387 Model 3389 for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation Model 3387 Model 3389 for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
deep brain stimulation with short & long pulse width for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
deep brain stimulation with short & long pulse width for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
deep brain stimulation with short & long pulse width for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation, DBS for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation, implanted for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep brain stimulation(Active) + Deep brain stimulation(Sham) for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep brain stimulation(Active) + Deep brain stimulation(Sham) for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation(DBS) + Esketamine for depressive disorder, treatment-resistantPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deep cervical lymph node to venous bypass (DCLNV-BP) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep cervical lymphatic-venous anastomosis for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep cervical lymphatic-venous anastomosis, LVA for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deep Cervical Lymphaticovenous Anastomosis(DLVA) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Cervical Lymphaticovenous Anastomosis(DLVA) for lewy body diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Cervical lymphatlc-Venous Anastomosis Surgery for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deep cervical lymphovenous anastomosis (LVA) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Cervical Lymphovenous Anastomosis + Routine Treatment for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Cervical Lymphovenous Anastomosis + Routine Treatment for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Device-only fitting for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Device-only fitting for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Device: Directional Deep Brain Stimulation for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dexmedetomidine hydrochloride for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dexmedetomidine hydrochloride for stress disorders, traumatic, acutePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dextromethorphan and Bupropion Sustained-Release Tablets for major depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Diamorphine hydrochloride anhydrous for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Diet-as-Usual (DAU) + LCHF Ketogenic Diet for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Diet-as-Usual (DAU) + LCHF Ketogenic Diet for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Diet-as-Usual (DAU) + LCHF Ketogenic Diet for schizophreniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dietary vitamin D for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dimethyltryptamine for major depressive disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
Divalproex sodium for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Donanemab for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Donanemab for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
Donanemab for lewy body diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Donanemab + 2-Pyrazinecarboxamide, N-[3-[(4aR,7aS)-2-amino-6-(5-fluoro-2-pyrimidinyl)-4a,5,6,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a(4H)-yl]-4-fluorophenyl]-5-methoxy- for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Donanemab + Dexamethasone for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Donanemab + Nivegacetor for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Double Active: Active portable transcranial stimulation (ptES) and active internet-based behavioral therapy (iBT) for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dronabinol for marijuana abusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
DTT106 for erectile dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DynamiCare Health for opioid-related disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
E-Cigarette 7.2 mg nicotine for tobacco use disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
EB-1020 (Centanafadine) high dose for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
EB-1020 (Centanafadine) low dose for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ecig 24 mg nicotine for schizophreniaTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
edupression.com® for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
edupression.com® for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
EEG-based personalized TMS for stress disorders, post-traumaticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Electroacupuncture for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Electroacupuncture for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
electronic cigarette for tobacco use disorderTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Elunetirom for major depressive disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Emestedastat for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Emono for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Emraclidine for schizophreniaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Endd (njoy) for tobacco use disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Escitalopram + Esketamine + Venlafaxine + Duloxetine + SERTRALINE for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Esketamine for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Esketamine for major depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)7
Esketamine + Esketamine Hydrochloride + Ketamine Hydrochloride for bipolar disorderTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Esketamine + Esketamine Hydrochloride + Ketamine Hydrochloride for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Esketamine + Esketamine Hydrochloride + Ketamine Hydrochloride for major depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Esketamine + Esketamine Hydrochloride + Ketamine Hydrochloride for schizophreniaTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Esketamine Treatment as Usual (ESK) + Virtual-Reality-based mindfulness intervention for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Esketamine Treatment as Usual (ESK) + Virtual-Reality-based mindfulness intervention for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Esomeprazole for autistic disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Estradiol for major depressive disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Etanercept for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Evenamide 15 mg bid for schizophrenia, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
ExAblate 4000 Type 2.1 for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Exablate Model 4000 Type 2 + ADUCANUMAB + LECANEMAB for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Exablate Model 4000 Type 2 + ADUCANUMAB + LECANEMAB for cognitive dysfunctionPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Exercise + Control for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Experimental regimen for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Facilitate tDCS + CR for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Facilitate tDCS + CR for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Facilitate tDCS + CR for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fasedienol for phobia, socialPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)7
Fasudil for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fasudil for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbiota Transplant (FMT) for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbiota Transplant (FMT) + Vancomycin + NITAZOXANIDE for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Flibanserin for sexual dysfunctions, psychologicalTrial registered, as of 19 Nov 2026 (not yet checked by a person)11
FLUOROETHOXYBENZOVESAMICOL F-18 for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fluoxetine for alcoholismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fluoxetine for depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fluoxetine for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)5
Fluoxetine for obsessive-compulsive disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fluoxetine + Dextromethorphan for body dysmorphic disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fluoxetine + Dextromethorphan for obsessive-compulsive disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fluoxetine + Imipramine for dysthymic disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fluoxetine + Imipramine for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Focused Transcranial Ultrasound for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Focused Transcranial Ultrasound for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Full Dose Midomafetamine HCl for stress disorders, post-traumaticTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Gam-COVID-Vac for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
GammaSense Stimulation device for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Gantenerumab for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)3
GENUS device (Active Settings) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
GENUS device (Active Settings) for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ginkgo for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy + MIDOMAFETAMINE for stress disorders, post-traumaticPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy Program for bipolar disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy Program for psychotic disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy Program + naltrexone and bupropion (combination) for bipolar disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy Program + naltrexone and bupropion (combination) for psychotic disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy Program + Phentermine-Topiramate for bipolar disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy Program + Phentermine-Topiramate for psychotic disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy Program + Semaglutide for bipolar disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy Program + Semaglutide for psychotic disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
GV-971 for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
GV-971 + MEMANTINE for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
GXV-813 for schizophreniaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Hatha Yoga Practice Group for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
HB-1 for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Healthy Activity Program (HAP) for depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Heart to Heart Yoga for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High doses of Thiamine y Biotin for huntington diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
High intensity whole-body infrared heating for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
High Monetary Incentive (HMI) + Message-Based Psychotherapy (MBP) for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High Monetary Incentive (HMI) + Message-Based Psychotherapy with Monthly Video-Chat Psychotherapy for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High Monetary Incentive (HMI) + Message-Based Psychotherapy with Weekly Video-Chat Psychotherapy for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High Monetary Incentive (HMI) + Video-Chat Psychotherapy (VCP) for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High THC Cannabis for combat disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High THC Cannabis for marijuana abuseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High THC Cannabis for stress disorders, post-traumaticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High-intensity inpatient MDMA-assisted psychotherapy for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
High-intensity Mediterranean diet intervention for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
HS-10380 for schizophreniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
hUC-MSC-Exos Nasal Spray for autism spectrum disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
human Mesenchymal Stem Cells for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
human Mesenchymal Stem Cells for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Hydroxyzine Hydrochloride for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Hydroxyzine Hydrochloride + Lidocaine for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Hyperbaric Oxygen Therapy for combat disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ibogaine hydrochloride for opioid-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Iclepertin for schizophreniaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Increasing control over stimulant use and physical health through incentivized rehabilitation for substance-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Individualized rTMS (transcranial magnetic stimulation) for depressive disorderTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Integration Therapy for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Integration Therapy for dissociative disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
intermittent theta burst stimulation (iTBS) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
intermittent theta burst stimulation (iTBS) + METHYLPHENIDATE HYDROCHLORIDE for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
intra-striatal rAAV5-miHTT for huntington diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
intracavernous platelet rich plasma therapy for erectile dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
ITI-1284 10 mg for generalized anxiety disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ITI-1284 20 mg for generalized anxiety disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ITP Stimulation for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
JNJ-64042056 for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
KarX-EC + KarXT for autism spectrum disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
KarX-EC + KarXT for autistic disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
KarX-EC + KarXT for schizophreniaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
KarXT for autistic disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
KarXT for schizophreniaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine for cocaine-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Ketamine for major depressive disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Ketamine for stress disorders, post-traumaticPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine Hydrochloride for alcoholismPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine Hydrochloride for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine Hydrochloride for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine Hydrochloride for stress disorders, post-traumaticTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine-Assisted Psychotherapy (KAP) for anxiety disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine-Assisted Psychotherapy (KAP) for stress disorders, post-traumaticPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic Diet for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)3
Ketogenic Diet for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Ketogenic Diet for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Ketogenic Diet for psychotic disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic Diet for schizophreniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic Diet + Non-ketogenic Diet for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic diet intervention for psychotic disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic diet intervention for schizophreniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic foodstuffs for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic Therapy for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
kudzu extract, puerarin for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lacosamide for bipolar disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
LCHF Ketogenic Diet for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Lecanemab for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
Lecanemab for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
LECANEMAB + Etalanetug for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Left DLPFC tDCS for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Leucovorin for asperger syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Leucovorin for autism spectrum disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)5
Leucovorin for autistic disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Levoleucovorin calcium for autism spectrum disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Lifus for substance-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
light box + Wake Therapy + LITHIUM for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
light box + Wake Therapy + LITHIUM for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Lithium for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)4
Lithium carbonate + perospirone hydrochloride for depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lithium sulphate prolonged-release 660 mg for bipolar disorderTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
low intensity focused ultrasound (LIFU) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low Monetary and Alternative Incentive (LMAI) + Message-Based Psychotherapy (MBP) for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low Monetary and Alternative Incentive (LMAI) + Message-Based Psychotherapy with Monthly Video-Chat Psychotherapy for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low Monetary and Alternative Incentive (LMAI) + Message-Based Psychotherapy with Weekly Video-Chat Psychotherapy for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low Monetary and Alternative Incentive (LMAI) + Video-Chat Psychotherapy (VCP) for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low-intensity focused ultrasound for cocaine-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low-intensity focused ultrasound for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low-Intensity Focused Ultrasound + Low-Intensity Focused Ultrasound - sham for anxiety disordersTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Low-Intensity Focused Ultrasound + Low-Intensity Focused Ultrasound - sham for opioid-related disordersTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Lurasidone for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
LY-2599666 for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
LY-2599666 for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
LY3002813 for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
LY3002813-IV for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
LY3002813-SC for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lysergide d-tartrate for attention deficit disorder with hyperactivityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lysergide d-tartrate for generalized anxiety disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Mad for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Magnesium for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents + Neuronavigation-guided single-element focused ultrasound transducer + Positron Emission Tomography (PET) + FLORBETAPIR F-18 + PERFLUTREN for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Manualized therapy + MIDOMAFETAMINE for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Manualized therapy + Midomafetamine HCl for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Matched Placebo (oral gummy) + Δ9-Tetrahydrocannabivarin (oral gummy) for tobacco use disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Matching Intramuscular Placebo + IBOGAINE HYDROCHLORIDE for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Matching Placebo (E2814) + LECANEMAB for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
MDMA Assisted Therapy for opioid-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
MDMA Assisted Therapy for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
MDMA-assisted Cognitive Processing Therapy (MDMA-aCPT) + MIDOMAFETAMINE for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mdma-at for combat disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mdma-at for stress disorders, post-traumaticPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Medtronic Activa PC+S System for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Medtronic Activa SC DBS, Lead Model 3387 for depressive disorder, treatment-resistantTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Medtronic Percept PC DBS system for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Medtronic Percept PC DBS system for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Medtronic SenSight Directional DBS lead for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Medtronic Summit RC+S DBS system for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Medtronic Summit RC+S DBS system for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Memantine for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
MEOPA (Nitrous Oxide/Oxygen Premix) for combat disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Message-based psychotherapy (MBP) for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Message-based psychotherapy (MBP) for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Message-Based Psychotherapy (MBP) + Message-Based Psychotherapy with Monthly Video-Chat Psychotherapy for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Message-Based Psychotherapy (MBP) + Message-Based Psychotherapy with Weekly Video-Chat Psychotherapy for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Message-Based Psychotherapy with Monthly Video-Chat Psychotherapy + Video-Chat Psychotherapy (VCP) for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Message-Based Psychotherapy with Weekly Video-Chat Psychotherapy + Video-Chat Psychotherapy (VCP) for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Metformin hydrochloride for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Methylphenidate hydrochloride for combat disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Methylphenidate hydrochloride for stress disorders, post-traumaticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Mevidalen for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Midazolam Placebo Solution + Esketamine for major depressive disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Midomafetamine for adjustment disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Midomafetamine for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Midomafetamine for combat disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Midomafetamine for stress disorders, post-traumaticPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)18
Midomafetamine for substance-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Midomafetamine HCl for stress disorders, post-traumaticPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
Midomafetamine Hydrochloride for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mindfulness-Based Stress Reduction for agoraphobiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mindfulness-Based Stress Reduction for generalized anxiety disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mindfulness-Based Stress Reduction for panic disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mindfulness-Based Stress Reduction for phobia, socialPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mindfulness-centered psilocybin-assisted therapy + Music-centered psilocybin-assisted therapy + Psilocybin for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Mindset for alcohol-related disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
MK-1167 for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
ML-007C-MA for psychotic disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ML-007C-MA for schizophreniaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Moderate doses of Thiamine y Biotin for huntington diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Modified deep cervical Lymphatic-Venous Anastomosis for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
MR guided low intensity focused ultrasound for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Music & Auditory Beat Stimulation for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Music and Theta Auditory Beat Stimulation for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Music Therapy for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
NanoLithium® NP03 for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Navigate for affective disorders, psychoticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Navigate for psychotic disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Navigate for schizophreniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Navigate for schizophrenia, childhoodTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
NBI-1117570 for schizophreniaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Next Generation Dome Helmet (NGDH) for substance-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Nicotinamide Riboside (NR) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Nicotinamide Riboside (NR) for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Nightmare Deconstruction and Reprocessing for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
NightWare for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)3
NightWare smartwatch configured to detect physiological signs of sympathetic activation during sleep, such as heart-rate spikes and movement patterns. for stress disorders, post-traumaticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
NightWare Therapeutic System for combat disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)4
NightWare Therapeutic System for stress disorders, post-traumaticTrial registered, as of 19 Nov 2026 (not yet checked by a person)4
Nitrous Oxide for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Nitrous Oxide for major depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
Nivegacetor for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nmdae for major depressive disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nmdae for schizophreniaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
NMDAE plus AIFA for schizophreniaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
NMS-01 for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Obicetrapib 10 mg for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Oculus VR headset for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Olanzapine for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Olanzapine and Fluoxetine combination (OFC) for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Olz/sam for schizophreniaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
omega-3 for antisocial personality disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Omega-3 supplemented drink for antisocial personality disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
one night of sleep deprivation and two FDG PET scans for bipolar disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
one night of sleep deprivation and two FDG PET scans for major depressive disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
ORG-34517 for combat disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
OT-led Exercise Group for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Oxcarbazepine for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Oxytocin for autism spectrum disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Pemvidutide for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Perospirone hydrochloride tablets for depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Personalized neuroprotective strategies : Vitamin B12, folinic acid, Omega 3, NAC for psychotic disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
PHEN/TPM ER (Qsymia®) for binge-eating disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for schizophreniaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for sexual dysfunctions, psychologicalTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + ADUCANUMAB for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)4
Placebo + ADUCANUMAB for cognitive dysfunctionTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Donanemab for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Escitalopram + Venlafaxine + Duloxetine + SERTRALINE for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Nimodipine for alcoholismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Psilocybin for major depressive disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Psilocybin + Propofol for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + SRP-1005 for huntington diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
placebo 2 tablets qhs for sexual dysfunctions, psychologicalTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo Nasal Spray for phobia, socialPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Placebo Nasal Spray - Placebo Nasal Spray for phobia, socialPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo of trazodone + Psilocybin for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Prolonged Exposure + MIDOMAFETAMINE for stress disorders, post-traumaticPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Prolonged exposure therapy + MIDOMAFETAMINE for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Prolonged exposure therapy + MIDOMAFETAMINE for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Propranolol for combat disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Propranolol for stress disorders, post-traumaticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psa for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)8
Psilocybin for anxiety disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)5
Psilocybin for bipolar disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for borderline personality disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for cocaine-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)8
Psilocybin for generalized anxiety disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for major depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)19
Psilocybin for obsessive-compulsive disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)4
Psilocybin for stress disorders, post-traumaticPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Psilocybin + MBCT therapy for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin + Modafinil for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin + PIMAVANSERIN for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin + PIMAVANSERIN + Modafinil for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin + Placebo for major depressive disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin + ZOLPIDEM for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin + ZOLPIDEM + Modafinil for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin + ZOLPIDEM + PIMAVANSERIN for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin + ZOLPIDEM + PIMAVANSERIN + Modafinil for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psychopharmacological treatment for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psychotherapy for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psychotherapy + Medication for opioid use disorder for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psychotherapy + MIDOMAFETAMINE for combat disordersTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Psychotherapy + MIDOMAFETAMINE for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Psychotherapy + Survey Administration + Psilocybin for anxiety disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Questionnaires for alcoholismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Questionnaires for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Quetiapine for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Randomized, staggered withdrawal phase for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Randomized, staggered withdrawal phase for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
real-time fMRI neurofeedback training for cocaine-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
real-time fMRI neurofeedback training + Ketamine for cocaine-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Receive tDCS+CR for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Receive tDCS+CR for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Receive tDCS+CR for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant varicella zoster virus glycoprotein e antigen for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant varicella zoster virus glycoprotein e antigen for dementiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Recovery Management Checkups (RMC) delivered by community-based agencies (RMC adopters) for alcoholismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Recovery Management Checkups (RMC) delivered by community-based agencies (RMC adopters) for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Relapse prevention cognitive behavioral therapy (CBT) for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
REPAIR Sleep for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
REPAIR Sleep for cognition disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
RGH-202 for phobia, socialTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Right DLPFC tDCS for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Risperidone for psychotic disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Risperidone for schizophreniaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Rituximab for psychotic disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
RP902 for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
rTMS treatment + Ketamine for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
S1B-408 for sexual dysfunctions, psychologicalTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Saccharomyces cerevisiae for autism spectrum disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sea-it for combat disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sea-it for stress disorders, post-traumaticPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semagludtide for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
Sense4Safety for cognitive dysfunctionPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sertraline for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
sertraline, lithium for bipolar disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
sertraline, lithium for major depressive disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Service-only Fitting for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Service-only Fitting for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
sex therapy + Flibanserin for sexual dysfunctions, psychologicalTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
SGB - Combined Solution of Bupivacaine + Ketamine Adjuvant for stress disorders, post-traumaticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
sham acupuncture + SSRIs for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Sham neurofeedback for borderline personality disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Shuganjieyu capsule for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Simple cognitive task for stress disorders, post-traumaticTrial registered, as of 19 Nov 2026 (not yet checked by a person)3
Simufilam for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
SmartSleep EEG recording headband + Ketamine for stress disorders, post-traumaticTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Sodium lactate for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sodium oligo-mannurarate 600mg for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sodium oligo-mannurarate 600mg for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sodium oligo-mannurarate 900mg for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sodium oligo-mannurarate 900mg for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sodium Oligomannate Capsules for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Solanezumab for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)7
Solanezumab for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Solizmestrocel for erectile dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Solriamfetol for binge-eating disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
SPT-300 for anxiety disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
SPT-300 for major depressive disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
SSRI/SNRI + Esketamine for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
SSRI/SNRI + Esketamine for major depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
STAM 1100mAh CE4 eGo Clearomizer for tobacco use disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Standardized kudzu for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT®) with the Magnus Neuromodulation System for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Step count goal for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Stimulation-ON for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Structured Integrated Reframing Therapy (SIRT) for major depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Structured Integrated Reframing Therapy (SIRT) for stress disorders, post-traumaticPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Structured Integrated Reframing Therapy (SIRT) + Psilocybin for major depressive disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Structured Integrated Reframing Therapy (SIRT) + Psilocybin for stress disorders, post-traumaticPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Supermicrosurgical Lymphaticovenular Anastomosis (LVA) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Supportive psychotherapy + Psilocybin for major depressive disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Supportive psychotherapy + Psilocybin + MICROCRYSTALLINE CELLULOSE for major depressive disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
tACS combined with 40 Hz sound stimulation for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Task-oriented resistance exercise for cognitive dysfunctionPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
TAU+CBT for pts+Family Intervention+CM. for affective disorders, psychoticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
TAU+CBT for pts+Family Intervention+CM. for psychotic disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
tDCS for depressive disorder, treatment-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
tDCS for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
TDCS - transcranial direct current stimulation for anxiety disordersTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
tDCS (Eldith DC-Stimulator (CE certified)) for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
tDCS over DLPFC for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
tDCS over DLPFC for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Testosterone undecanoate for sexual dysfunctions, psychologicalTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Therabot for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Therabot for feeding and eating disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Therapy + MIDOMAFETAMINE for stress disorders, post-traumaticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)3
Tirzepatide for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Tominersen for huntington diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Transcranial alternating current stimulation for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Transcranial Direct Current Stimulation for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)6
transcranial direct current stimulation (tDCS) for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Transcranial direct current stimulation (tDCS) on the Left DLPFC for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Transcranial direct current stimulation (tDCS) on the right VLPFC for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Transcranial Direct Current Stimulation + SERTRALINE for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
transcranial magnetic resonance guided focused ultrasound BBB disruption for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Trazodone 5mg + Psilocybin for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
TREATMENT ARM: Full dose for combat disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
TREATMENT ARM: Full dose for stress disorders, post-traumaticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Treatment with Ketone Supplement for opioid-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Treatment with Placebo for opioid-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
tributyrin for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
tributyrin for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Troculeucel for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Trontinemab for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Trontinemab for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tsa for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
TTYP01 Tablets (12mg or 18mg) for autism spectrum disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ulotaront for schizophreniaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes for erectile dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Valacyclovir for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Valacyclovir for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Valiltramiprosate for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Valproic acid for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)3
Vancomycin + NITAZOXANIDE for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Varenicline for marijuana usePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Varenicline for tobacco use disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Venlafaxine for generalized anxiety disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Vericiguat for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Video-chat Psychotherapy (VCP) for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Video-chat Psychotherapy (VCP) for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Viloxazine hydrochloride for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
Visuospatial Task (VST) for stress disorders, post-traumaticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vitamin d for seasonal affective disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vitamin D 100 micrograms for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Votoplam (blinded) for huntington diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
VR social musical exergame for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VR solo musical exergame for anxiety disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Walk-and-talk therapy for anxiety disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Wbh for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Whole-Body Hyperthermia for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Whole-Body Hyperthermia for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Whole-body hyperthermia + standard medical care for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Wujia Yizhi granules for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Wysa Digital Chatbot Program for [obsolete] disordered eating behaviorPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Xanomeline Enteric Capsule + Xanomeline/Trospium Chloride Capsule for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Xiaochaihu Granules (Low Dose) for depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Xingqi Daozhi Decoction for schizophreniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Yband(YDT-201N) for major depressive disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ziprasidone for bipolar disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Zonisamide for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1